To assess the tolerability of switching from Depakote Sprinkle Capsules or Depakote tablets to Depakote ER tablets in the pediatric population.

Inclusion Criteria:

• Male or female patient with a clinical diagnosis of epilepsy considered stable by the investigator.
• Must be in good physical health, on the same dose of all medications, including Depakote and other AEDs, for 2 week period prior to randomization.
• Minimum body weight of 37 lbs.

Exclusion Criteria:

• Six-month history of drug or alcohol abuse.
• Status epilepticus within 6 months prior to screening.
• Abnormal platelet or ALT/AST levels.